Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer
Clinical trial NCT06509126 · RECRUITING
Trial details
- NCT number
- NCT06509126
- Sponsor
- National Cancer Institute, Naples
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-12
- Primary completion
- 2028-01-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.